{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:35:05Z","timestamp":1751376905111},"reference-count":26,"publisher":"Stichting Nase","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rhin"],"abstract":"<jats:p>Background: Rhino-orbito-cerebral-mucormycosis (ROCM), a rare and potentially fatal disease was seen in increasing numbers during the COVID-19 pandemic. This study describes and compares the patient characteristics and outcomes in COVID-19 associated mucormycosis (CAM) and non-COVID-19 mucormycosis (non-CAM). Methodology: CAM patients (24 cases) were recruited from the COVID-19 period and non-CAM (24 controls) from the pre-COVID-19 period. Clinical data of the CAM group was collected retrospectively with 3 month outcomes prospectively. The non-CAM group data was collected retrospectively. Patient characteristics were compared and risk factors for mortality in ROCM were assessed. Results: Orbital symptoms [altered vision, restricted eye movements, ptosis] and intracranial involvement were higher in CAM patients on presentation. Similarly, the radiological involvement of orbit (orbital apex, superior orbital fissure) and intracranial cavity (intracranial thrombosis, cavernous sinus) was also higher in CAM patients. Newly detected diabetes was found only in CAM patients (29.2%). Although univariate analysis suggested an increased mortality risk in ROCM patients with orbital involvement, the multivariate analysis showed no increased risk with any of the parameters assessed, including COVID-19 positivity. Conclusions: Compared to the non-CAM, the disease presentation was severe in CAM with higher frequency of orbital and intracranial involvement. However, with early detection and treatment, the short term survival was comparable in both groups.<\/jats:p>","DOI":"10.4193\/rhin22.099","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T16:25:01Z","timestamp":1660148701000},"page":"0-0","source":"Crossref","is-referenced-by-count":2,"title":["Rhino-orbito-cerebral mucormycosis: patient characteristics in pre-COVID-19 and COVID-19 period"],"prefix":"10.4193","volume":"0","author":[{"given":"L.M.","family":"Cherian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Rupa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.R.","family":"Bright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Panicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"R.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Shyam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.M.","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Manesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Karuppusami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lenin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.G.","family":"Hansdak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"I.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ninan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kurian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mammen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kurien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2708","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1439-0507.2001.00656.x","article-title":"Mucormycoses","volume":"44","author":"J","year":"2001","unstructured":"1. J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses. 2001; 44: 253-260.","journal-title":"Mycoses"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s00405-005-0919-0","article-title":"Rhinocerebral mucormycosis: pathways of spread","volume":"262","author":"SM","year":"2005","unstructured":"2. Hosseini SM, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol. 2005; 262: 932-938.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.otc.2008.01.001","article-title":"Invasive Fungal Sinusitis and Complications of Rhinosinusitis","volume":"41","author":"VA","year":"2008","unstructured":"3. Epstein VA, Kern RC. Invasive Fungal Sinusitis and Complications of Rhinosinusitis. Otolaryngol ClinNorth Am. 2008; 41: 497-524.","journal-title":"Otolaryngol ClinNorth Am"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","unstructured":"4. Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019; 25: 26-34.","journal-title":"Clin Microbiol Infect"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF02907665","article-title":"Rhinocerebral mucormycosis: An analysis of probable mode of spread and its implication in an early diagnosis and treatment","volume":"57","author":"Kulk ar ni","year":"2005","unstructured":"5. Kulk ar ni NS, Bhide AR, Wadia RS. Rhinocerebral mucormycosis: An analysis of probable mode of spread and its implication in an early diagnosis and treatment. Indian J Otolaryngol Head Neck Surg. 2005; 57: 121-124.","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Kubin CJ, McConville TH, Dietz D, Zucker J, May M, Nelson B, et al. Characterization of bacterial and fungal infections in hospitalized patients with Coronavirus Disease 2019 and factors associated with health care-associated infections. Open Forum Infect Dis. 2021; 8: ofab201-ofab201.","DOI":"10.1093\/ofid\/ofab201"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","unstructured":"7. Gupta A, Madhavan MV, Sehgal K , Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020; 26: 1017-1032.","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0030-6665(00)80008-0","article-title":"An algorithmic approach to the diagnosis and management of invasive fungal rhinosinusitis in the immunocompromised patient","volume":"33","author":"Gillespie","year":"2000","unstructured":"8. Gillespie MB, O'Malley BW. An algorithmic approach to the diagnosis and management of invasive fungal rhinosinusitis in the immunocompromised patient. Otolaryngol Clin North Am. 2000; 33: 323-334.","journal-title":"Otolaryngol Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter Epidemiologic Study of Coronavirus Disease -Associated Mucormycosis, India","volume":"27","author":"Patel","year":"2021","unstructured":"9. Patel A, Agarwal R, Rudramurthy SM, Shevkani M, Xess I, Sharma R, et al. Multicenter Epidemiologic Study of Coronavirus Disease -Associated Mucormycosis, India. Emerg Infect Dis. 2021; 27: 2349-2359.","journal-title":"Emerg Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/myc.12897","article-title":"Mucormycosis-A clinicoepidemiological review of cases over 10 years","volume":"62","author":"Manesh","year":"2019","unstructured":"10. Manesh A, Rupali P, Sullivan MO, Mohanraj P, Rupa V, George B, et al. Mucormycosis-A clinicoepidemiological review of cases over 10 years. Mycoses. 2019; 62: 391-398.","journal-title":"Mycoses"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00405-020-05879-y","article-title":"Avoiding repeated surgery in patients with acute invasive fungal sinusitis","volume":"277","author":"Malleshappa","year":"2020","unstructured":"11. Malleshappa V, Rupa V, Varghese L, Kurien R. Avoiding repeated surgery in patients with acute invasive fungal sinusitis. Eur Arch Otorhinolaryngol. 2020; 277: 1667-1674.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref11","unstructured":"12. Covid Management Guidelines India Group - Anti-inflammatory Working Group. Systemic Corticosteroids. Covid Guidelines India; Published online on July 15, 2021; URL: https:\/\/indiacovidguidelines.org\/systemic-corticosteroids."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1111\/myc.13338","article-title":"COVID-19-associated mucormycosis: An updated systematic review of literature","volume":"64","author":"Pal","year":"2021","unstructured":"13. Pal R, Singh B, Bhadada SK, Banerjee M, Bhogal RS, Hage N, et al. COVID-19-associated mucormycosis: An updated systematic review of literature. Mycoses. 2021; 64: 1452-1459.","journal-title":"Mycoses"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/IOP.0000000000002030","article-title":"Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study","volume":"37","author":"Dave","year":"2021","unstructured":"14. Dave TV, Gopinathan Nair A, Hegde R, Vithalani N, Desai S, Adulkar N, et al. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study. Ophthalmic Plast Reconstr Surg. 2021; 37: 488-495.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11046-021-00584-8","article-title":"Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World","volume":"19","author":"Muthu","year":"2021","unstructured":"15. Muthu V, Rudramurthy SM, Chakrabarti A , Agarwal R. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World. Mycopathologia. 2021; 19: 1-16.","journal-title":"Mycopathologia"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/lary.23912","article-title":"Survival outcomes in acute invasive fungal sinusitis: a systematic review and quantitative synthesis of published evidence","volume":"123","author":"Turner","year":"2013","unstructured":"16. Turner JH, Soudry E, Nayak JV, Hwang PH. Survival outcomes in acute invasive fungal sinusitis: a systematic review and quantitative synthesis of published evidence. Laryngoscope. 2013; 123: 1112-1118.","journal-title":"Laryngoscope"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19","volume":"383","author":"Ackermann","year":"2020","unstructured":"17. Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N Engl J Med. 2020; 383: 120-128.","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Ibrahim AS. Host-iron assimilation: pathogenesis and novel therapies of mucormycosis. Mycoses. 2014; 57 Suppl 3: 13-17.","DOI":"10.1111\/myc.12232"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19. Sen M, Honavar SG, Bansal R, Sengupta S, Rao R, Kim U, et al. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 2021; 69: 1672-1690.","DOI":"10.4103\/ijo.IJO_1565_21"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/jof5010026","article-title":"Global Epidemiology of Mucormycosis","volume":"21","author":"Prakash","year":"2019","unstructured":"20. Prakash H, Chakrabarti A. Global Epidemiology of Mucormycosis. J Fungi (Basel). 2019; 21: 26.","journal-title":"J Fungi (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","unstructured":"21. Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. DiabetesMetab Syndr. 2021; 15: 102146.","journal-title":"DiabetesMetab Syndr"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.mce.2008.09.020","article-title":"The sweeter side of ACE2: physiological evidence for a role in diabetes","volume":"302","author":"SM","year":"2009","unstructured":"22. Bindom SM, Lazartigues E. The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol. 2009; 302: 193-202.","journal-title":"Mol Cell Endocrinol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/jof7040298","article-title":"When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis","volume":"7","author":"John","year":"2021","unstructured":"23. John TM, Jacob CN, Kontoyiannis DP. When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis. J Fungi (Basel). 2021; 7: 298.","journal-title":"J Fungi (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1001\/jamaophthalmol.2021.5201","article-title":"Cumulative mortality and factors associated with outcomes of mucormycosis after COVID-19 at a multispecialty tertiary care center in India","volume":"140","author":"Choksi","year":"2022","unstructured":"24. Choksi T, Agrawal A, Date P, et al. Cumulative mortality and factors associated with outcomes of mucormycosis after COVID-19 at a multispecialty tertiary care center in India. JAMA Ophthalmol. 2022; 140: 66-72.","journal-title":"JAMA Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/alr.22172","article-title":"A multi-institutional review of outcomes in biopsy-proven acute invasive fungal sinusitis","volume":"8","author":"Wandell","year":"2018","unstructured":"25. Wandell GM, Miller C, Rathor A, Wai TH, Guyer RA, Schmidt RA, et al. A multi-institutional review of outcomes in biopsy-proven acute invasive fungal sinusitis. Int Forum Allergy Rhinol. 2018; 8:1459-1468.","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1038\/s41598-020-60719-7","article-title":"Treatment outcomes in acute invasive fungal rhinosinusitis extending to the extra-sinonasal area","volume":"10","author":"Nam","year":"2020","unstructured":"26. Nam SH, Chung Y-S, Choi YJ, Lee JH, Kim JH. Treatment outcomes in acute invasive fungal rhinosinusitis extending to the extra-sinonasal area. Scientific Reports. 2020; 10: 3688.","journal-title":"Scientific Reports"}],"container-title":["Rhinology journal"],"original-title":[],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T04:44:47Z","timestamp":1727757887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.rhinologyjournal.com\/Abstract.php?id=3019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":26,"journal-issue":{"issue":"0","published-online":{"date-parts":[[2022,8,10]]}},"URL":"https:\/\/doi.org\/10.4193\/rhin22.099","relation":{},"ISSN":["0300-0729"],"issn-type":[{"type":"print","value":"0300-0729"}],"subject":[],"published":{"date-parts":[[2022,8,10]]}}}